Ani Pharmaceuticals Inc. (ANIP)
NASDAQ · Healthcare
Ani Pharmaceuticals Inc. Shareholder Equity 2009–2025
Ani Pharmaceuticals Inc. annual shareholder equity history from 2010 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Ani Pharmaceuticals Inc. shareholder equity as of December 31, 2025: 540.7M, a 33.95% increase year-over-year.
- Ani Pharmaceuticals Inc. shareholder equity for 2025 were 540.7M, a 33.95% increase from 2024.
- Ani Pharmaceuticals Inc. shareholder equity for 2024 were 403.7M, a 6.72% decrease from 2023.
- Ani Pharmaceuticals Inc. shareholder equity for 2023 were 432.7M, a 37.95% increase from 2022.
- Ani Pharmaceuticals Inc. shareholder equity for 2022 were 313.7M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Ani Pharmaceuticals Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $541 |
| 2024 | $404 |
| 2023 | $433 |
| 2022 | $314 |
| 2021 | $334 |
| 2020 | $196 |
| 2019 | $213 |
| 2018 | $197 |
| 2017 | $175 |
| 2016 | $170 |
| 2015 | $160 |
| 2014 | $140 |
| 2013 | $41 |
| 2012 | $-43 |
| 2011 | $-34 |
Ani Pharmaceuticals Inc. Shareholder Equity — FAQ
Ani Pharmaceuticals Inc. (ANIP) shareholder equity over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ANIP's shareholder equity history?
The chart and table above show Ani Pharmaceuticals Inc.'s shareholder equity by year and by quarter, including the growth rate.